Once demonstrated the prognostic inflammation markers role, this cohort study is aimed to verify the hypothesis that non-specific markers as ESR, CRP and fibrinogen, could give prognostic indications in patients with acute myocardial infarction with persistent ST-segment elevation (STEMI), underwent primary angioplasty (PCI). The gene discussed is CRP; the disease is myocardial infarction.